Warfarin and stroke outcomes in hemodialysis patients with atrial fibrillation

Journal of the American Society of Nephrology

Volumn 20, Issue 10, 2009, Pages 2090-2092

  Genovesi, Simonetta ^a,b   Santoro, Antonio ^c  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b SAN GERARDO HOSPITAL   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

WARFARIN; ANTICOAGULANT AGENT;

ANTICOAGULANT THERAPY; BLEEDING; EDITORIAL; HEART ATRIUM FIBRILLATION; HEMODIALYSIS PATIENT; HUMAN; KIDNEY FAILURE; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; STROKE; INTERNATIONAL NORMALIZED RATIO; NOTE;

ANTICOAGULANTS; ATRIAL FIBRILLATION; HUMANS; INTERNATIONAL NORMALIZED RATIO; RENAL DIALYSIS; STROKE; WARFARIN;

EID: 70349909965     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2009070754     Document Type: Editorial

References (15)

1. Genovesi S, Pogliani D, Faini A, Valsecchi MG, Riva A, Stefani F, Acquistapace I, Stella A, Bonforte G, DeVecchi A, DeCristofaro V, Buccianti G, Vincenti A: Prevalence of atrial fibrillation and associated factors in a population of long-term haemodialysis patients. Am J Kidney Dis 46: 897-902, 2005 (Pubitemid 41505464)
2. Genovesi S, Vincenti A, Rossi E, Pogliani D, Acquistapace I, Stella A, Valsecchi MG: Atrial fibrillation and morbidity and mortality in a cohort of long-term hemodialysis patients. Am J Kidney Dis 51: 255-262, 2008
3. Reynolds MW, Fahrbach K, Hauch O, Wygant G, Estok R, Cella C, Nalysnyk L: Warfarin anticoagulation and outcomes in patients with atrial fibrillation. A systemic review and metaanalysis. Chest 126: 1938-1945, 2004
4. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): A randomised controlled trial. Lancet 367: 1903-1912, 2006
5. Hylek EM, Singer DE: Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med 120: 897-902, 1994
6. Guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol 48: 854-906, 2006 (Pubitemid 44175743)
7. Torn M, Cannegieter SC, Bollen WLE, van der Meer FJM, van der Wall EE, Frits R, Rosendaal FR: Optimal level of oral anticoagulant therapy for the prevention of arterial thrombosis in patients with mechanical heart valve prostheses, atrial fibrillation, or myocardial infarction. Arch Intern Med 169: 1203-1209, 2009
8. Morgagni GB: Opera Omnia, Ex Typographia Remondiniana, Venice, Italy, 1764
9. Sohal AS, Gangji AS, Crowther MA, Treleaven D: Uremic bleeding: pathophysiology and clinical risk factors. Thromb Res 118: 417-422, 2006 (Pubitemid 44067195)
10. Chan KE, Lazarus JM, Thadhani R, Hakim RM: Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation. J Am Soc Nephrol 20: 2223-2233, 2009
11. Reinecke H, Brand E, Mesters R, Schabitz WR, Fisher M, Pavenstadt H, Breithardt G: Dilemmas in the management of atrial fibrillation in chronic kidney disease. J Am Soc Nephrol 20: 705-711, 2009
12. Seliger SL, Gillen DL, Tirschwell D, Wasse H, Kestenbaum BR, Stehman- Breen COI: Risk factors for incident stroke among patients with end-stage renal disease. J Am Soc Nephrol 14: 2623-2631, 2003 (Pubitemid 37169349)
13. Seliger SL, Gillen DL, Longstreth WT, Kestenbaum B, Stehman-Breen O: Elevated risk of stroke among patients with end-stage renal disease. Kidney Int 64: 603-609, 2003 (Pubitemid 36871932)
14. Ezecowitz MD, Connolly S, Parekh A, Reilly PA, Varrone J, Wang S, Oldgren J, Themeles E, Wallentin L, Yusuf S: Rationale and design of RE-LY: Randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatran. Am Heart J 157: 805-810, 2009
15. Turpie AGG: New oral anticoagulants in atrial fibrillation. Eur Heart J 29: 155-165, 2007